logo-loader
viewPhagoMed Biopharma

PhagoMed looks to raise around $18M to scale up its bacterial infections treatment

PhagoMed Biopharma GmbH CEO Alexander Belcredi spoke with Proactive at the Biotech Showcase 2020 in San Francisco. The Austria-based biotech's pipeline is focused on treating biofilm-forming bacterial infections, which are all in preclinical development. The company specializes in fighting multi-resistant bacteria, where multiple antibiotics have become ineffective.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Phunware helps new, unnamed railroad customer better engage...

Phunware Inc. (NASDAQ:PHUN) COO Randall Crowder tells Proactive the fully-integrated enterprise cloud platform for mobile has unveiled a first national railway customer for its mobile corporate campus solution. Crowser says the new, unnamed national transportation customer will leverage...

2 hours, 32 minutes ago

2 min read